Tag: risk management

Scaling QbD From Single Trials to Enterprise-Level Frameworks Scaling QbD From Single Trials to Enterprise-Level Frameworks Quality by Design (QbD) is a systematic approach that ensures quality is built into clinical development products and processes. One of the significant challenges that organizations face is scaling the concepts of QbD from individual clinical trials to an…

Read More “Scaling QbD From Single Trials to Enterprise-Level Frameworks” »

Engaging Sites and Patients in QbD Activities and Feedback Loops Quality by Design (QbD) represents a paradigm shift in clinical research, emphasizing the importance of planning, systematic approaches, and continuous improvement throughout the clinical trial lifecycle. This tutorial guide will provide clinical operations, regulatory affairs, and medical affairs professionals with a structured approach to engaging…

Read More “Engaging Sites and Patients in QbD Activities and Feedback Loops” »

Future Directions: QbD, Real-World Data and Digital Trial Ecosystems The landscape of clinical trial operations is rapidly evolving with the integration of innovative methodologies, including Quality by Design (QbD), the utilization of real-world data (RWD), and the establishment of digital trial ecosystems. These advancements aim to enhance clinical trial management and improve data quality, thereby…

Read More “Future Directions: QbD, Real-World Data and Digital Trial Ecosystems” »

QbD Approaches in Decentralized, Adaptive and Platform Trial Designs Understanding Quality by Design (QbD) in Decentralized, Adaptive, and Platform Trials Quality by Design (QbD) has transformed the landscape of clinical trial methodology, emphasizing a proactive, systematic approach to development. With the rise of decentralized, adaptive, and platform trial designs, understanding how QbD principles can be…

Read More “QbD Approaches in Decentralized, Adaptive and Platform Trial Designs” »

Regulatory Perspectives on QbD in Clinical Development Programs Regulatory Perspectives on QbD in Clinical Development Programs Quality by Design (QbD) has emerged as a significant strategy in the development of pharmaceuticals and biologics. This approach emphasizes the importance of pre-identifying potential risks and ensuring robustness throughout the development lifecycle, particularly in the context of registrational…

Read More “Regulatory Perspectives on QbD in Clinical Development Programs” »

Case Studies: QbD-Driven Trials With Fewer Amendments and Deviations Case Studies: QbD-Driven Trials With Fewer Amendments and Deviations Quality by Design (QbD) principles have significantly transformed the landscape of clinical trials, especially in the context of registrational clinical trials. Leveraging QbD not only optimizes trial design but also reduces the likelihood of amendments and deviations,…

Read More “Case Studies: QbD-Driven Trials With Fewer Amendments and Deviations” »

Integrating QbD Into SOPs, Training and QMS Governance Integrating QbD Into SOPs, Training and QMS Governance Quality by Design (QbD) represents a paradigm shift in the approach to clinical trials, enhancing the efficiency, effectiveness, and regulatory compliance of clinical research. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs…

Read More “Integrating QbD Into SOPs, Training and QMS Governance” »

Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes The integration of Quality by Design (QbD) principles into clinical research has become a focal point for improving the efficiency and effectiveness of clinical trials. This step-by-step tutorial guide aims to equip clinical…

Read More “Measuring the Impact of QbD on Timelines, Cost and Inspection Outcomes” »

Identifying Critical-to-Quality Factors During Protocol Development Identifying Critical-to-Quality Factors During Protocol Development Introduction to Critical-to-Quality Factors in Clinical Trials The development of clinical trial protocols is a critical step in ensuring the success of pharmaceutical research and ultimately, the therapeutic benefits for patients. Within this framework, identifying Critical-to-Quality (CTQ) factors during protocol development has emerged…

Read More “Identifying Critical-to-Quality Factors During Protocol Development” »